Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.230
+0.040 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Akso Health Group Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2.41 | 2.41 | 13.18 | 6 | - | 3.87 | Upgrade
|
| Other Revenue | - | - | - | - | - | 3.04 | Upgrade
|
| Revenue | 2.41 | 2.41 | 13.18 | 6 | - | 6.91 | Upgrade
|
| Revenue Growth (YoY) | -81.68% | -81.68% | 119.69% | - | - | 87.12% | Upgrade
|
| Cost of Revenue | 2.29 | 2.29 | 11.91 | 5.39 | - | - | Upgrade
|
| Gross Profit | 0.12 | 0.12 | 1.27 | 0.61 | - | 6.91 | Upgrade
|
| Selling, General & Admin | 8.76 | 8.76 | 15.54 | 2.67 | 2.03 | 22.98 | Upgrade
|
| Operating Expenses | 8.76 | 8.76 | 15.54 | 3.06 | 2.09 | 23.33 | Upgrade
|
| Operating Income | -8.64 | -8.64 | -14.27 | -2.46 | -2.09 | -16.42 | Upgrade
|
| Interest Expense | - | - | - | -0.8 | -2.15 | -2.5 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.59 | -0.59 | 1.14 | -0.75 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.14 | 0.14 | 0.06 | 0 | -0.05 | 1.25 | Upgrade
|
| EBT Excluding Unusual Items | -9.09 | -9.09 | -13.07 | -4.01 | -4.29 | -17.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -29.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.02 | Upgrade
|
| Pretax Income | -9.09 | -9.09 | -13.07 | -4.01 | -4.29 | -46.87 | Upgrade
|
| Income Tax Expense | 0.02 | 0.02 | 0.02 | 0.09 | - | 0.49 | Upgrade
|
| Earnings From Continuing Operations | -9.12 | -9.12 | -13.08 | -4.1 | -4.29 | -47.36 | Upgrade
|
| Earnings From Discontinued Operations | -0.4 | -0.4 | 11.84 | -12.75 | -30.53 | -23.83 | Upgrade
|
| Net Income to Company | -9.52 | -9.52 | -1.25 | -16.85 | -34.83 | -71.2 | Upgrade
|
| Minority Interest in Earnings | 0.06 | 0.06 | -0.11 | -0 | - | - | Upgrade
|
| Net Income | -9.46 | -9.46 | -1.36 | -16.85 | -34.83 | -71.2 | Upgrade
|
| Net Income to Common | -9.46 | -9.46 | -1.36 | -16.85 | -34.83 | -71.2 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 47 | 23 | 20 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 47 | 23 | 20 | 16 | 16 | Upgrade
|
| Shares Change (YoY) | 106.30% | 106.30% | 15.07% | 22.06% | 0.17% | 0.13% | Upgrade
|
| EPS (Basic) | -0.20 | -0.20 | -0.06 | -0.85 | -2.14 | -4.38 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.22 | -0.08 | -0.85 | -2.15 | -4.38 | Upgrade
|
| Free Cash Flow | 1.35 | 1.35 | -3.25 | -8.63 | 10.06 | -58.48 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.03 | -0.14 | -0.43 | 0.62 | -3.60 | Upgrade
|
| Gross Margin | 5.06% | 5.06% | 9.63% | 10.09% | - | 100.00% | Upgrade
|
| Operating Margin | -357.78% | -357.78% | -108.23% | -40.94% | - | -237.43% | Upgrade
|
| Profit Margin | -391.78% | -391.78% | -10.32% | -280.85% | - | -1029.70% | Upgrade
|
| Free Cash Flow Margin | 55.97% | 55.97% | -24.68% | -143.81% | - | -845.75% | Upgrade
|
| EBITDA | - | - | -14.25 | -2.44 | -2.07 | -16.3 | Upgrade
|
| EBITDA Margin | - | - | -108.09% | -40.63% | - | -235.69% | Upgrade
|
| D&A For EBITDA | - | - | 0.02 | 0.02 | 0.02 | 0.12 | Upgrade
|
| EBIT | -8.64 | -8.64 | -14.27 | -2.46 | -2.09 | -16.42 | Upgrade
|
| EBIT Margin | - | - | -108.23% | -40.94% | - | -237.43% | Upgrade
|
| Revenue as Reported | 2.41 | 2.41 | 13.18 | 6 | - | 6.91 | Upgrade
|
| Advertising Expenses | 0.17 | 0.17 | 0.01 | - | - | 0.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.